The Australian Institute of Health and Welfare (AIHW) s report A Snapshot of Rheumatoid Arthritis show management of the disease has changed considerably over the last decade." />

Management of Rheumatoid Arthritis Changed Considerably

By Ryan Mccann
Friday, 31 May, 2013



<!--
/* Font Definitions */
@font-face
{font-family:Arial;
panose-1:2 11 6 4 2 2 2 2 2 4;
mso-font-charset:0;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;
mso-font-charset:0;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:-536870145 1107305727 0 0 415 0;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;
mso-font-charset:0;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:-1610611985 1073750139 0 0 159 0;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-parent:"";
margin-top:0cm;
margin-right:0cm;
margin-bottom:10.0pt;
margin-left:0cm;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:Calibri;
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:Calibri;
mso-fareast-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;
mso-fareast-language:EN-US;}
p
{mso-style-noshow:yes;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman";
mso-fareast-language:EN-AU;}
.MsoChpDefault
{mso-style-type:export-only;
mso-default-props:yes;
font-size:11.0pt;
mso-ansi-font-size:11.0pt;
mso-bidi-font-size:11.0pt;
font-family:Calibri;
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:Calibri;
mso-fareast-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
.MsoPapDefault
{mso-style-type:export-only;
margin-bottom:10.0pt;
line-height:115%;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 90.0pt 72.0pt 90.0pt;
mso-header-margin:36.0pt;
mso-footer-margin:36.0pt;
mso-paper-source:0;}
div.WordSection1
{page:WordSection1;}
-->The Australian Institute of Health and Welfare (AIHW) s report A Snapshot of Rheumatoid Arthritis show management of the disease has changed considerably over the last decade.
“According to recent statistics from the Australian Bureau of Statistics, rheumatoid arthritis is estimated to affect about two per cent of Australians. This condition can develop at any age, but is more common in those aged 55 and older and is more common in women than in men,” said AIHW spokesperson Louise York.
The report shows that while the prevalence of rheumatoid arthritis remained relatively unchanged over the last decade, the way this condition is managed has changed significantly during this time.
In 2003, a new class of medicine, referred to as biologic disease-modifying anti-rheumatic drugs (bDMARDs), became available for treatment of rheumatoid arthritis in Australia, broadening the treatment options. As expected, the use of these new treatments has risen significantly in recent years.
“The number of times pharmacotherapy, such as corticosteroids and bDMARDs, was administered during admitted hospital care more than doubled from 2004-05 to 2010-11, up from 2,608 to 6,932 occasions,” Ms York said.
The hospitalisation rate for the condition also rose from 30 hospitalisations per 100,000 people to 53 per 100,000 people between 2001-02 and 2010-11, although it is uncertain how much of this increase is attributable to pharmaceutical interventions provided in hospitals.
In 2008-09, the estimated direct health expenditure alone on rheumatoid arthritis was $318.7 million, with a substantial portion of this spent on prescription medications ($273.6 million, or 86 per cent). “The indirect cost of managing rheumatoid arthritis is currently unknown but the impact of rheumatoid arthritis on those with the condition is significant,” Ms York said. “Rheumatoid arthritis may also lead to reduced workforce participation, increased costs of managing the condition, and an increased impact on carers.”

Related Articles

Two copies of Christchurch may protect against Alzheimer's

New treatments were investigated after a woman at high risk for early-onset Alzheimer's...

More support needed after self-harm to reduce suicide risk

A high risk of suicide following hospital discharge for self-harm highlights the need for early...

Embracing telehealth: understanding the barriers to adoption in Australia

Is telehealth a potential silver bullet to help precious medical resources go further?


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd